FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387520009> ?p ?o ?g. }

• W4387520009 endingPage "102875" @default.
• W4387520009 startingPage "102875" @default.
• W4387520009 abstract "Drugs for diabetes are required to demonstrate cardiovascular safety through CV outcome trials (CVOT). The pre-defined end-points for cardiovascular outcome studies may not be sufficient to capture all clinically relevant atherosclerotic cardio vascular disease (ASCVD) events particularly peripheral arterial disease (PAD).We planned a scoping review and searched database to identify CVOT conducted in population with diabetes measuring lower limb events due to PAD as the primary outcome measure. We also searched CVOT for reported differential cardiovascular outcomes in population with PAD.We identified that CV outcomes are measured as 3 point major adverse cardiovascular outcomes (3P-MACE) that includes nonfatal MI and nonfatal stroke or 4P-MACE that included additional unstable angina which is further expanded to 5P-MACE by the inclusion of hospitalization for heart failure (HHF). These CV end points are captured as surrogate for CV mortality based on the biological plausibility of relation between the surrogate and final outcome from pathophysiological studies. We found the prevalence of PAD is no lesser than other CV events in people with diabetes. Moreover, PAD contributes to the significant morbidity associated with diabetes as a surrogate for mortality. However, none of the CVOT with anti-diabetic drugs include PAD events as primary outcome measure despite the inclusion of 6-25 % participants with PAD in major CVOT. PAD outcomes are objectively measurable with tibial arterial waveforms and clinical end-point as lower extremity amputation. PAD outcomes do improve with treatment including intensive glycemic control and novel oral anticoagulants. We suggest the inclusion of PAD to MACE as a pre-specified outcome for a comprehensive capture of major adverse vascular event in future studies for people with diabetes.MACE should be expanded to include PAD event as major adverse vascular event in cardiovascular outcome studies since PAD is clinically relevant and objectively measurable in diabetes." @default.
• W4387520009 created "2023-10-12" @default.
• W4387520009 creator A5034897442 @default.
• W4387520009 creator A5036441656 @default.
• W4387520009 creator A5069102879 @default.
• W4387520009 creator A5093041237 @default.
• W4387520009 date "2023-11-01" @default.
• W4387520009 modified "2023-10-18" @default.
• W4387520009 title "A paradigm shift for cardiovascular outcome evaluation in diabetes: Major adverse cardiovascular events (MACE) to major adverse vascular events (MAVE)" @default.
• W4387520009 cites W1474133614 @default.
• W4387520009 cites W1969271537 @default.
• W4387520009 cites W1979470591 @default.
• W4387520009 cites W1980903642 @default.
• W4387520009 cites W1991487766 @default.
• W4387520009 cites W2010116948 @default.
• W4387520009 cites W2011243379 @default.
• W4387520009 cites W2012905414 @default.
• W4387520009 cites W2014179250 @default.
• W4387520009 cites W2016819629 @default.
• W4387520009 cites W2031167232 @default.
• W4387520009 cites W2065292319 @default.
• W4387520009 cites W2083291499 @default.
• W4387520009 cites W2089706804 @default.
• W4387520009 cites W2096237115 @default.
• W4387520009 cites W2106509295 @default.
• W4387520009 cites W2106664741 @default.
• W4387520009 cites W2108670857 @default.
• W4387520009 cites W2110664743 @default.
• W4387520009 cites W2112912403 @default.
• W4387520009 cites W2116384002 @default.
• W4387520009 cites W2123946565 @default.
• W4387520009 cites W2140136269 @default.
• W4387520009 cites W2142830692 @default.
• W4387520009 cites W2143239235 @default.
• W4387520009 cites W2146264128 @default.
• W4387520009 cites W2150718275 @default.
• W4387520009 cites W2155355295 @default.
• W4387520009 cites W2159509855 @default.
• W4387520009 cites W2164416219 @default.
• W4387520009 cites W2170205796 @default.
• W4387520009 cites W2275461818 @default.
• W4387520009 cites W2329731360 @default.
• W4387520009 cites W2406453816 @default.
• W4387520009 cites W2425644022 @default.
• W4387520009 cites W2516683303 @default.
• W4387520009 cites W2519510391 @default.
• W4387520009 cites W2552730765 @default.
• W4387520009 cites W2561256275 @default.
• W4387520009 cites W2562521254 @default.
• W4387520009 cites W2626446274 @default.
• W4387520009 cites W2749380187 @default.
• W4387520009 cites W2749709425 @default.
• W4387520009 cites W2756910166 @default.
• W4387520009 cites W2770821084 @default.
• W4387520009 cites W2793760979 @default.
• W4387520009 cites W2883426762 @default.
• W4387520009 cites W2894746763 @default.
• W4387520009 cites W2900413769 @default.
• W4387520009 cites W2905401804 @default.
• W4387520009 cites W2916920217 @default.
• W4387520009 cites W2923426929 @default.
• W4387520009 cites W2939222610 @default.
• W4387520009 cites W2942291658 @default.
• W4387520009 cites W2948612418 @default.
• W4387520009 cites W2979558564 @default.
• W4387520009 cites W2999077691 @default.
• W4387520009 cites W2999937316 @default.
• W4387520009 cites W3012199281 @default.
• W4387520009 cites W3013428853 @default.
• W4387520009 cites W3046814568 @default.
• W4387520009 cites W3087206479 @default.
• W4387520009 cites W3089283105 @default.
• W4387520009 cites W3106961347 @default.
• W4387520009 cites W3183402545 @default.
• W4387520009 cites W3208468967 @default.
• W4387520009 cites W4206445899 @default.
• W4387520009 cites W4213074600 @default.
• W4387520009 cites W4243656112 @default.
• W4387520009 cites W4292543961 @default.
• W4387520009 cites W4321163265 @default.
• W4387520009 doi "https://doi.org/10.1016/j.dsx.2023.102875" @default.
• W4387520009 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37844433" @default.
• W4387520009 hasPublicationYear "2023" @default.
• W4387520009 type Work @default.
• W4387520009 citedByCount "0" @default.
• W4387520009 crossrefType "journal-article" @default.
• W4387520009 hasAuthorship W4387520009A5034897442 @default.
• W4387520009 hasAuthorship W4387520009A5036441656 @default.
• W4387520009 hasAuthorship W4387520009A5069102879 @default.
• W4387520009 hasAuthorship W4387520009A5093041237 @default.
• W4387520009 hasConcept C126322002 @default.
• W4387520009 hasConcept C127413603 @default.
• W4387520009 hasConcept C134018914 @default.
• W4387520009 hasConcept C141341695 @default.
• W4387520009 hasConcept C164705383 @default.
• W4387520009 hasConcept C177713679 @default.
• W4387520009 hasConcept C1862650 @default.
• W4387520009 hasConcept C197934379 @default.

• next